SEC Extends Review of Dogecoin and XRP ETF Proposals

The SEC has extended its review period for Dogecoin and XRP ETFs. Originally slated for decision in May 2025, these delays affect applications from 21Shares and Grayscale Investments, reflecting SEC’s thorough approach to crypto-related ETFs.

The SEC’s decision-making process involves evaluating if proposals meet regulatory standards. Paul Atkins, current SEC Chair and known crypto advocate, leads oversight with a focus on compliance and investor protection, emphasizing careful scrutiny over hasty approvals. The SEC stated it needs more time ‘to consider the proposed rule change and the issues raised therein.’ SEC Rule Filing for Cboe BZX, Regulation Details

Market reactions have remained stable despite the SEC’s delays. XRP and Dogecoin prices show minimal volatility, indicating investor expectations align with typical regulatory timelines. Institutional interest in crypto ETFs remains high, as evidenced by filings and market behavior.

Financial implications for the market are likely minimal in the short term. The SEC’s delay highlights the political importance of balancing innovation with regulatory rigor, impacting sentiment among crypto enthusiasts and institutional investors focused on long-term strategy.

The regulatory delay implies no immediate approvals before Q3 2025, with market analysts predicting potential decisions in early Q4. This timeline aligns with historical patterns of crypto ETF evaluations. “A bunch of XRP ETPs have dates in next few days. If we’re gonna see early approvals from the SEC on any of these assets — I wouldn’t expect to see them until late June or early July at absolute earliest. More likely to be in early Q4.” – James Seyffart, ETF Analyst, Bloomberg

Insights suggest potential outcomes including heightened scrutiny on market manipulation and compliance mechanisms. Historical regulatory trends indicate prolonged assessment of crypto ETFs to safeguard against fraud while accommodating growing institutional investments. SEC Rule Filing for NYSE Arca, Regulatory Information